The results of a randomized clinical trial funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in children with type 2 diabetes show that children and adolescents treated with a combination of metformin and Avandia (rosiglitazone) had better glycemic control than children treated with metformin alone...

Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that...

Since its recent commercial launch, the Spring Universal Infusion Set has been particularly well received by parents of children with type 1 diabetes. Specifically, the following features were highly favored: the automatic all-in-one inserter (which gives young patients the independence to do their own site changes), the lightning-fast...

The European Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion on the extended use of Novo Nordisk’s basal insulin analogue, insulin detemir, in children with type 1 diabetes, aged two to five years. The CHMP decision was made after the review of data demonstrating that insulin detemir is an equally...

Children with Diabetes (CWD) anounced that it has signed a two year partnership with Novo Nordisk to develop and distribute resources that will help newly diagnosed children with type 1 diabetes adjust to their new lifestyle. Every year approximately 15,600 children and adolescents in the United States are diagnosed with type 1 diabetes.  As...

U.S. Supreme Court Justice Sonia Sotomayor will meet with 150 children and teens with type 1 diabetes during the 2011 Children’s Congress which takes place June 20-22 in Washington D.C.  Justice Sotomayor, who was diagnosed with type 1 diabetes at the age of eight, will share her experiences of type 1 diabetes as she’s pursued...

New clinical trial data just published in Pediatric Diabetes shows that Levemir (insulin detemir), Novo Nordisk’s basal insulin analogue, is an equally efficacious treatment option for two to five year-old children with type 1 diabetes, compared with human basal insulin, but is associated with lower hypoglycemic risk. Children ...

NEW YORK, (March 14, 2011) – Approximately 150 children and teenagers throughout the U.S., and several from around the world have been selected to travel to Washington, D.C. this summer to represent their state and country and remind Congress and the Administration of the critical need to find better treatments and a cure for a disease...

The Chicago Athenaeum Museum of Architecture and Design in cooperation with The European Centre for Architecture, Art, Design and Urban Studies have chosen to award Novo Nordisk a 2010 GOOD DESIGN™ Award for the NovoPen Echo, a new insulin pen designed specifically with the needs of children in mind. The award is given to a product...

A new study has found that keeping babies off cow’s milk may help prevent the development of type 1 diabetes in children. The study followed 230 Finnish babies who received formula because breast milk was not available. Half of the babies received standard cow’s milk formula while the other half were given a special formula...